Kairos Biotech Ltd
12188499
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 04/09/2019
DIRECTOR
BRITISH · UNITED KINGDOM · Age 64
Also on 1 other board
Persons with Significant Control
Mr Michael Bunce
British · United Kingdom · Age 64
Marian Prysau, Pen Y Cefn, Mold, CH7 5BQ
Notified 04/09/2019
Charges0 outstanding
ECHIUMBIO HOLDING BV
CompanyRankvs 330+ SIC 72110 peers77
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/09/2025
Net Worth
£675k
Balance sheet strength
Cash
£489k
Cash in the bank
Net Current Assets
£475k
Working capital
Current Assets
£491k
Current Liabilities
£16k
Fixed Assets
£217k
Debtors
£2k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 30.85 | -£502k |
| 2024 | 37.51 | +£617k |
| 2023 | 22.96 | +£623k |
| 2022 | 20.95 | -£29k |
| 2021 | 2.49 | — |
Derived from filed accounts. Not audited figures.